The Europe Robotic Radiotherapy Market was valued at $285.7 Million in 2023 and projected to reach to $479.6 Million by 2028, representing a compound annual growth rate of 10.9%. Europe's robotic radiotherapy market is positioned for sustained growth through 2028, supported by increasing cancer incidence, aging populations, and healthcare systems' commitment to adopting cutting-edge treatment modalities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's robotic radiotherapy market reached $285.7 million in 2023 and is projected to grow to $479.6 million by 2028, representing a robust 10.9% CAGR, driven by technological advancement and clinical adoption.
Germany leads Europe's market with $153.8 million, followed by the UK ($103.4 million) and France ($84.5 million), reflecting strong healthcare infrastructure and investment in precision oncology across Western Europe.
Rising healthcare expenditure across European nations, coupled with government support for advanced cancer treatment technologies, is accelerating the adoption of robotic radiotherapy systems in clinical settings.
Growing awareness and acceptance of precision medicine and personalized cancer treatment approaches in Europe are propelling demand for robotic radiotherapy solutions among healthcare providers and oncology centers.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | STEREOTACTIC RADIATION THERAPY (Technology) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 11.9% from 2023 to 2028 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 1.08 (2023) |
| Revenue Forecast (Billions) | ~USD 1.9 (2028) |
| Segments Covered | Product, Technology, Type, Application, End User |
5 segment dimensions are covered across the global market.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS | 174.6 | 194.1 | 214.9 | 238.3 | 263.5 | 291.1 | 321.6 | 355 | 392.6 | 10.5 |
| INDEPENDENT RADIOTHERAPY CENTERS | 32.8 | 36.6 | 41.6 | 47.4 | 53.8 | 60.9 | 69 | 78 | 87 | 12.9 |
| TOTAL | 207.4 | 230.7 | 256.5 | 285.7 | 317.3 | 352.1 | 390.6 | 432.9 | 479.6 | 10.9 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 153.8 Million |
| France | USD 84.5 Million |
| UK | USD 103.4 Million |
| Italy | USD 39.1 Million |
| Spain | USD 38.8 Million |
| Rest Of Europe | USD 60 Million |
Europe's robotic radiotherapy market was valued at $285.7 million in 2023 and is expected to reach $479.6 million by 2028.
Europe's robotic radiotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.9% from 2023 to 2028.
Key drivers include Europe's aging population, rising cancer incidence, advanced healthcare infrastructure, favorable reimbursement policies, and increasing adoption of precision medicine technologies.
Western European nations with advanced healthcare systems and higher healthcare expenditure are leading in robotic radiotherapy adoption and infrastructure investment.
Europe's 10.9% CAGR is slightly lower than the global 11.9% CAGR, reflecting Europe's mature healthcare market and established treatment protocols.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the robotic radiotherapy market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the robotic radiotherapy market. The primary sources from the demand side include medical OEMs, Analytical instrument OEMs, CDMOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
To know about the assumptions considered for the study, download the pdf brochure
In this report, the global robotic radiotherapy market size was arrived at by using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the robotic radiotherapy business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.
To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size from the market size estimation process explained above, the global robotic radiotherapy market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the robotic radiotherapy market was validated using both top-down and bottom-up approaches.
Robotic radiotherapy market is a segment of the radiotherapy industry that focuses on the development and supply of advanced technology for radiotherapy treatment. Robotic radiotherapy consists of several components, including advanced imaging technologies, treatment planning software, and robotic treatment delivery systems. These components work together to provide a fully automated, integrated radiation therapy solution and play a crucial role in modern cancer treatment by enabling precise, efficient, and safe delivery of radiation therapy to patients.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global robotic radiotherapy market report:
Full forecast, segment splits, and company analysis for all Robotic Radiotherapy Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report